Physician profile
William Bae
NPI 1538699079
$1,438.73
in general payments reported to CMS, 2019-2025
11 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $67.24 · 2022: $21.36 · 2023: $664 · 2024: $563 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.15 |
| Education | $161.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $561.52 | 2023-2025 | Lynparza, Tagrisso |
| Avadel Cns Pharmaceuticals, LLC | $219.15 | 2024 | Lumryz |
| E.R. Squibb & Sons, L.L.C. | $114.95 | 2023 | Opdivo |
| Regeneron Healthcare Solutions, INC. | $103.75 | 2023 | Libtayo |
| Tempus Ai, INC | $97.92 | 2025 | Xt Cdx |
| Pfizer INC. | $92.04 | 2024 | |
| Janssen Biotech, INC. | $89.99 | 2024 | Erleada |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.24 | 2020 | |
| Aveo Pharmaceuticals, INC. | $44.18 | 2024 | |
| Glaxosmithkline, LLC. | $26.63 | 2023 | Jemperli, Zejula |
| Merck Sharp & Dohme LLC | $21.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.